In stem cell transplants, which are used for the treatment of leukemia, the patient's hematopoietic system is eliminated and replaced by hematopoietic cells from donors. Even though the amount of complications occurring in ...
Feb 9, 2023
0
2
In hemophilia A cases, the body either partially or completely lacks the blood coagulation factor VIII (FVIII), or the factor is formed incorrectly. Patients usually receive FVIII that comes from donor blood or is produced ...
Feb 7, 2023
0
3
Could humanity finally be gaining the upper hand in our age-old fight against cancer?
Feb 2, 2023
0
22
A new study by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) suggests a way to re-energize critical killer ...
Jan 24, 2023
0
54
Inhibiting a particular protein in cancer-killing immune cells might improve the long-term effectiveness of CAR T-cell and other immune checkpoint therapies, according to a new study by researchers at The Ohio State University ...
Jan 24, 2023
0
53
Scientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have discovered that a protein, called Menin, contributes to abnormal deactivation of specific genes in cancer cells.
Jan 13, 2023
0
43
Severe inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study shows.
Jan 11, 2023
0
45
Soon after infection, HIV-1 establishes a life-long presence by forming viral reservoirs in the body—cells that are infected with HIV but not actively producing new viruses. Antiretroviral therapy (ART) reduces HIV levels ...
Jan 10, 2023
0
32
The recent years have seen a wave of adoptive cell therapies (ACTs), a type of immunotherapy in which T cells (T cell transfer therapy) and other immune cells are obtained from patients, activated and multiplied outside the ...
Jan 10, 2023
0
53
Researchers at UCSF have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells.
Jan 2, 2023
0
65
